Home › Funds › EVOLVE PRIVATE WEALTH, LLC › UTHR
EVOLVE PRIVATE WEALTH, LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
EVOLVE PRIVATE WEALTH, LLC reported holding 12,502 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.32% of its reported portfolio and ranking #50 among its reported holdings. EVOLVE PRIVATE WEALTH, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EVOLVE PRIVATE WEALTH, LLC's UTHR position evolved
EVOLVE PRIVATE WEALTH, LLC first disclosed a stake in UTHR in Q4 2025 at 14,020 shares (US$6.8M). The position peaked in Q1 2026 at 12,913 shares, worth US$7.7M. Across 4 filings, EVOLVE PRIVATE WEALTH, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,502 shares valued at US$6.8M — a reduction of -233 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 14.02K | $6.83M | New |
| Q1 2026 | 12.91K | $7.66M | Reduce |
| Q2 2026 | 12.73K | $6.90M | Reduce |
| Q3 2026 | 12.50K | $6.77M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on EVOLVE PRIVATE WEALTH, LLC
FAQ
How long has EVOLVE PRIVATE WEALTH, LLC held UTHR?
EVOLVE PRIVATE WEALTH, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is EVOLVE PRIVATE WEALTH, LLC's current position in UTHR?
As of Q3 2026, EVOLVE PRIVATE WEALTH, LLC holds 12.50K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $6.77M, representing 0.32% of its reported portfolio and ranking #50.
Has EVOLVE PRIVATE WEALTH, LLC been buying or selling UTHR?
In the latest 13F filing (Q3 2026), EVOLVE PRIVATE WEALTH, LLC reduced its position in UTHR. The position peaked in Q1 2026 at 12.91K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.